| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
470,413
|
445,356
|
471,929
|
504,617
| | Cost of Revenue | 308,682 | 297,501 | 308,639 | 326,159 | | |
Gross Profit
|
161,731
|
147,855
|
163,290
|
178,458
| |
|
Operating Expenses |
|
Research Development | 13,616 | 12,923 | 13,395 | 12,460 |
|
Selling General and Administrative | 38,254 | 31,700 | 36,085 | 35,530 |
|
Non Recurring | 1,676 | 25,215 | 6,487 | 7,887 |
|
Others | 33,386 | 36,370 | 36,082 | 36,199 |
|
|
|
Total Operating Expenses | 86,932 | 106,208 | 92,049 | 92,076 | | | |
Operating Income or Loss
|
74,799
|
41,647
|
71,241
|
86,382
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (2,453) | (9,674) | 11,070 | (10,576) |
|
Earnings Before Interest And Taxes | 72,346 | 31,973 | 82,311 | 75,806 |
|
Interest Expense | 24,135 | 24,927 | 24,967 | 24,928 |
|
Income Before Tax | 48,211 | 7,046 | 57,344 | 50,878 |
|
Income Tax Expense | 13,546 | (63,895) | 15,838 | 24,760 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 34,665 | 70,941 | 41,506 | 26,118 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
34,665
|
70,941
|
41,506
|
26,118
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
34,665
|
70,941
|
41,506
|
26,118
|
|